In contrast, overexpression of PDPK1 in RCC cells was able to promote cell survival in the conditions of CYD-6-17 (Figure 4c) by increasing β-catenin, cyclin D1, and cyclin E along with decreased p21 and p27 (Supplementary Figure 5A). Here, PDPK1 is linked to renal cell carcinoma.